Clinical Trial: Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%
Brief Summary: The aim of this study is to investigate the utility of a technological based rating scale for assessing improvement in plaque psoriasis with Clobex spray treatment.
Detailed Summary:
Sponsor: Galderma Laboratories, L.P.
Current Primary Outcome: Subject Reported Target Lesion Severity Score. [ Time Frame: 2 weeks ]
Original Primary Outcome: Relationship Between Digital Photographs of a Target Lesion and Investigator an Subject Reported Severity Scores [ Time Frame: 2 weeks ]
Current Secondary Outcome:
- Investigator Reported Effectiveness Scores [ Time Frame: 2 weeks ]
- Subject Reported Effectiveness Scores [ Time Frame: 2 weeks ]
Original Secondary Outcome: Same as current
Information By: Galderma Laboratories, L.P.
Dates:
Date Received: June 26, 2013
Date Started: July 2013
Date Completion:
Last Updated: September 3, 2014
Last Verified: August 2014